Last reviewed · How we verify
Ultrasound-guided Suprascapular Nerve Block — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Ultrasound-guided Suprascapular Nerve Block (Ultrasound-guided Suprascapular Nerve Block) — Abant Izzet Baysal University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ultrasound-guided Suprascapular Nerve Block TARGET | Ultrasound-guided Suprascapular Nerve Block | Abant Izzet Baysal University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ultrasound-guided Suprascapular Nerve Block CI watch — RSS
- Ultrasound-guided Suprascapular Nerve Block CI watch — Atom
- Ultrasound-guided Suprascapular Nerve Block CI watch — JSON
- Ultrasound-guided Suprascapular Nerve Block alone — RSS
Cite this brief
Drug Landscape (2026). Ultrasound-guided Suprascapular Nerve Block — Competitive Intelligence Brief. https://druglandscape.com/ci/ultrasound-guided-suprascapular-nerve-block. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab